195 related articles for article (PubMed ID: 3728526)
1. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
Zinner SH; Dudley M; Blaser J
Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
[TBL] [Abstract][Full Text] [Related]
2. Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients.
Bodey GP; Feld R; Burgess MA
Am J Med Sci; 1976; 271(2):179-86. PubMed ID: 773180
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Johnson DE; Thompson B
Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
Klastersky J
Arch Intern Med; 1982 Oct; 142(11):1984-7. PubMed ID: 6215007
[TBL] [Abstract][Full Text] [Related]
5. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
Peterson LR; Gerding DN; Moody JA; Fasching CE
Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087
[TBL] [Abstract][Full Text] [Related]
6. Empiric antibiotic therapy for granulocytopenic cancer patients.
Schimpff SC
Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
[TBL] [Abstract][Full Text] [Related]
7. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
Klastersky J; Glauser MP; Schimpff SC; Zinner SH; Gaya H
Antimicrob Agents Chemother; 1986 Feb; 29(2):263-70. PubMed ID: 3521475
[TBL] [Abstract][Full Text] [Related]
9. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
[TBL] [Abstract][Full Text] [Related]
10. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
Granowetter L; Wells H; Lange BJ
Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
[TBL] [Abstract][Full Text] [Related]
12. Gram-positive bacteraemia in granulocytopenic cancer patients.
EORTC International Antimicrobial Therapy Cooperative Group
Eur J Cancer; 1990; 26(5):569-74. PubMed ID: 2144743
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
14. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.
J Clin Oncol; 1983 Oct; 1(10):597-603. PubMed ID: 6366126
[TBL] [Abstract][Full Text] [Related]
15. A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.
Gibson J; Date L; Joshua DE; Young GA; Wilson A; Benn R; Benson W; Iland H; Vincent PC; Kronenberg H
Aust N Z J Med; 1989 Oct; 19(5):417-25. PubMed ID: 2686610
[TBL] [Abstract][Full Text] [Related]
16. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
Chin NX; Jules K; Neu HC
Eur J Clin Microbiol; 1986 Feb; 5(1):23-8. PubMed ID: 2938945
[TBL] [Abstract][Full Text] [Related]
17. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies.
Martino P; Venditti M; Petti MC; Mandelli F; Serra P
Infection; 1985; 13(3):125-9. PubMed ID: 3928495
[TBL] [Abstract][Full Text] [Related]
18. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
Pickering LK; Rutherford I
J Pharmacol Exp Ther; 1981 May; 217(2):345-9. PubMed ID: 6453219
[TBL] [Abstract][Full Text] [Related]
19. In vitro models in the study of antibiotic therapy of infections in neutropenic patients.
Zinner SH; Blaser J
Am J Med; 1986 May; 80(5C):40-4. PubMed ID: 3717188
[TBL] [Abstract][Full Text] [Related]
20. Carbenicillin plus cephalothin or cefazolin as therapy for infections in neutropenic patients.
Bodey GP; Valdivieso M; Feld R; Rodriguez V; McCredie K
Am J Med Sci; 1977; 273(3):309-18. PubMed ID: 326048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
